The federal government will reimburse states for costs they incurred in paying drug claims that should have been covered by the Medicare Part D program. CMS also said the Bush Administration will pressure Part D plans to reimburse states for the cost of claims that the insurers should have paid. The federal government will pay states the difference between what they actually paid for the drugs and what the Rx plans allow, as well as the administrative costs of running stop-gap programs. The federal reimbursement ends on Feb. 15.
Mental Health and CBD: What's the Latest Info
October 27th 2022Drug Topics® is joined by Dr. Alex Capano, Chief Science Officer at Ananda Professional to discuss what CBD is used for mental health, where research should go next, and how to ensure that patients are getting effective CBD products.
Ohio Attorney General Sues Express Scripts and Prime Therapeutics For Price Fixing
March 30th 2023The suit alleges that Express Scripts, Prime and Prime customer Humana Pharmacy Solutions are able to share drug pricing and rebate information to increase prices for insulins, biologics and cancer drugs.
2 Clarke Drive
Cranbury, NJ 08512